BNTX - BioNTech SE
97.465
-2.845 -2.919%
Share volume: 676,999
Last Updated: 03-13-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$100.31
-2.84
-0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 05-08-2023 | 08-07-2023 | 11-06-2023 | 03-20-2024 | 05-06-2024 | |
| Cash flow financing | -317.614 M | -176.682 M | -315.840 M | -50.645 M | -8.424 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -738.592 M | 4.771 B | 750.526 M | 1.156 B | -342.687 M | |
| Net income | 547.565 M | -206.980 M | 169.920 M | 517.988 M | -340.311 M | |
| Depreciation | 34.236 M | 34.576 M | 41.858 M | 92.088 M | 41.364 M | |
| Changes in inventories | 462.410 M | 487.991 M | 439.824 M | 395.455 M | 373.036 M | |
| Changes in receivables | 7.033 B | 2.889 B | 2.118 B | 2.383 B | 1.771 B | |
| Investing Cashflow | -801.831 M | -2.489 B | -1.216 B | -3.182 B | -2.489 B | |
| Net Borrowings | -14.176 B | -17.286 B | -17.066 B | -18.567 B | -17.337 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -59.750 M | -336.056 M | -148.552 M | -234.834 M | -147.853 M | |
| Cash Change | 13.241 B | 15.400 B | 14.279 B | 12.895 B | 9.695 B |